⌘K

Login Start Free

Home/Filings/4/0001144204-10-009096

4//SEC Filing

STOLICK DAVID 4

Accession 0001144204-10-009096

CIK 0001137883other

View on SEC.gov Company Profile

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 5:14 PM ET

Size

11.1 KB

Accession

0001144204-10-009096

Insider Transaction Report

Form 4

Period: 2010-02-12

BRAINSTORM CELL THERAPEUTICS INCBCLI

Chief Financial Officer

Transactions

Sale
Common Stock
2010-02-12$0.36/sh−5,000$1,800→ 395,000 total
Sale
Common Stock
2010-02-16$0.36/sh−3,000$1,080→ 392,000 total
Sale
Common Stock
2010-02-16$0.36/sh−140,000$50,400→ 252,000 total
Sale
Common Stock
2010-02-17$0.36/sh−2,000$720→ 250,000 total
Exercise/Conversion
Stock Option (right to buy)
2010-02-12+400,000→ 0 total
Exercise: $0.15Exp: 2015-02-13→ Common Stock (400,000 underlying)

Footnotes (1)

[F1]The option is fully vested and exercisable

Documents

1 file

4
v175059_ex.xmlPrimary

Issuer

BRAINSTORM CELL THERAPEUTICS INC

CIK 0001137883

Entity typeother

Related Parties

1

filerCIK 0001318693

Filing Metadata

Form type: 4
Filed: Feb 18, 7:00 PM ET
Accepted: Feb 19, 5:14 PM ET
Size: 11.1 KB

View on SEC.gov